Matteson, D M <br/><br/>
Inhibition of experimental melanin protein-induced uveitis (EMIU) by targeting nitric oxide via phosphatidylcholine-specific phospholipase C.  [electronic resource] 

 -  Journal of autoimmunity  Sep 1999 
 - 197-204 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0896-8411 
<br/><br/><label>Standard No.: </label>10.1006/jaut.1999.0319  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis--drug effects<br/>Autoimmune Diseases--chemically induced<br/>Bridged-Ring Compounds--therapeutic use<br/>Down-Regulation<br/>Enzyme Induction--drug effects<br/>Eye Proteins--immunology<br/>Fas Ligand Protein<br/>Female<br/>Melanins--immunology<br/>Membrane Glycoproteins--isolation & purification<br/>Nitric Oxide--metabolism<br/>Nitric Oxide Synthase--biosynthesis<br/>Nitric Oxide Synthase Type II<br/>Norbornanes<br/>Rats<br/>Rats, Inbred Lew<br/>Thiocarbamates<br/>Thiones--therapeutic use<br/>Type C Phospholipases--antagonists & inhibitors<br/>Uvea--pathology<br/>Uveitis--chemically induced